Analyst Daily

Market Tracker: 200-Day MA Watch Kura Oncology, Inc. (NASDAQ:KURA)

Watching recent stock price activity, we are noting that Kura Oncology, Inc. (NASDAQ:KURA) has recently crossed above its 200-day moving average. Shares recently hit the 12.95 mark, and were seen trading 61.29% away from the 200-day moving average at the time of writing. Traders and investors may be closely watching current stock levels in relation to popular moving averages such as the 200-day MA. Stock price crosses of key moving averages may be used to help identify certain entry or exit points, and possible shifts in the current trend. Investors may also be focused on various other moving average time-frames. At present levels, the stock has been spotted trading 50.84% off of the 50-day moving average. Bringing the focus in closer, we can see that the share price has been trading 58.85% away from the 20-day moving average.

Taking a look at recent trading session data, Kura Oncology, Inc. (NASDAQ:KURA) shares have moved 0.00% from the start of the period. Further, company shares have been recently trading -6.16% away from the 52 week high and 223.75% away from the 52 week low. Zooming in closer, the stock has been recently recorded at -6.16% away from the 50 day high and 119.49% off of the 50 day low. The average volume is currently around 617.88. Investors may be watching shares for trading volume that is out of the ordinary. A large increase or decrease in trading volume may indicate that other factors are in play. Investors will typically take into consideration how long the unusual volume is sustained.

Sell-side analysts that regularly cover the stock have offered price targets and recommendations on Kura Oncology, Inc. (NASDAQ:KURA). Investors often keep close tabs on how these Street analysts are viewing company shares. Currently, the consensus target price for the company is $17.75. The consensus recommendation provided by covering analysts is presently 1.40. This number lands on a scale from 1 to 5. Following this scale, a rating of a 1 or a 2 would indicate a consensus Buy recommendation. A rating of 4 or 5 would represent a consensus Sell recommendation. A rating of 3 would indicate a Hold recommendation.

With the recent stock price activity, investors may be trying to gauge which way the stock is going to trend heading into the second half of the year. Taking a look back at some stock price performance numbers for Kura Oncology, Inc. (NASDAQ:KURA), we have noted that performance for the previous week is 9.75%. If we head back to the start of the calendar year, the stock has performed 119.49%. Looking back over the past 52-weeks, shares have performed 110.57%. Over the last month, company shares are 99.23%. For the last quarter, the stock has performed 62.89%. Checking in quickly on recent volatility numbers, we can see that shares have been recorded at 13.12% for the week, and 10.50% for the last month.

By